FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals By: Benzinga via Benzinga June 10, 2015 at 10:52 AM EDT A key regulatory advisory panel recommended approval of a cholesterol treatment under joint development by Sanofi SA ... Read More >> Related Stocks: Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR